4//SEC Filing
Ezekowitz Alan 4
Accession 0000899243-22-024528
CIK 0001680581other
Filed
Jun 28, 8:00 PM ET
Accepted
Jun 29, 5:00 PM ET
Size
12.4 KB
Accession
0000899243-22-024528
Insider Transaction Report
Form 4
Ezekowitz Alan
Director
Transactions
- Other
Stock Option (right to buy)
2022-06-28−500→ 14,500 totalExercise: $11.82Exp: 2030-12-02→ Common Stock (500 underlying) - Award
Stock Option (right to buy)
2022-06-27+19,000→ 19,000 totalExercise: $5.22Exp: 2032-06-26→ Common Stock (19,000 underlying)
Footnotes (2)
- [F1]This option was granted on June 27, 2022 and is scheduled to vest with respect to all shares on the first anniversary of the grant date or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date, subject to continued service.
- [F2]No value was received for the cancellation of these stock options, which were originally granted on December 3, 2020.
Issuer
Fulcrum Therapeutics, Inc.
CIK 0001680581
Entity typeother
Related Parties
1- filerCIK 0001780209
Filing Metadata
- Form type
- 4
- Filed
- Jun 28, 8:00 PM ET
- Accepted
- Jun 29, 5:00 PM ET
- Size
- 12.4 KB